When Volume Matters, Immunoassay Systems Deliver
...arge and small laboratories. Abbott Diagnostics, a division of Abbott Laboratories, Abbott Park, Ill., describes its AxSYM as the leading immunoassay system in the world. It is used in more than 10,000 laboratories across the globe. This system combines continuous access, random access and STAT processing wit...Prothrombin Time Comes in Small (CLIA-Waived) Packages
...che Diagnostics Corporation, Indianapolis, Ind., a division of Swiss F. Hoffmann-La Roche Ltd, produces the CoaguChek S System, designed for health care professionals to enable on-the-spot analysis of coagulation levels during mobile emergency treatment, in hospital and in general practice. The device employs...Lab Automation Networks Proliferating
...ration with analytic devices, Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland, says that its RSD 800 and RSD 800A Preanalytic Systems Manager (PSM) products offer state-of-the-art sample handling functions and powerful data management all from one system. The systems sample flow ...Genetic Analysis Systems Enter the Clinical Mainstream
...ality of life. Vysis, Inc., Downers Grove, Ill., a division of Abbott Laboratories, has gained FDA approval for its Aneuvysion assay, the only FDA cleared product to test for prenatal aneuploidy. Vysis offers an expansive line of DNA FISH (fluorescence in situ hybridization) probes for evaluation of chromosom...Hemoglobin Testing at the Point of Care
...th data management capabilities. GDS Technology, a division of Stanbio Laboratory, Boerne, Texas, produces the STATSite MHgb, based on the azidemethemoglobin method and able to use either finger stick or venous whole blood samples. The company says that this CLIA-waived device is the first palm-sized, battery...Immunoassay Systems - Your Laboratory Workhorse
...rge and small laboratories. Abbott Diagnostics, a division of Abbott Laboratories, Abbott Park, Ill., describes its AxSYM as the leading immunoassay system in the world. It is used in more than 10,000 laboratories across the globe. This system combines continuous access, random access and STAT processing w...Urinalysis Analyzers: Large Capabilities in Every Size Device
...mong urinalysis products from Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd., Basle, Switzerland, ...Chem is $625. Hypoguard USA, Inc., Edina, Minn., a division of British firm Medisys, manufactures the DiaScreen 50 Urine Chemistry Analyzer, designed for use wi......igh unmet medical need. About Tibotec Tibotec, a division of Janssen-Cilag, brings innovative productsfor HI...nts in Europe, the Middle East and Africa.This new division was created within the Janssen-Cilag companies inOctober 2005 to focus on patients' and health care ...... ismarketed in the U.S. by Tibotec Therapeutics, a division of OrthoBiotech Products, L.P. In the European Uni...ther countries, PREZISTA is marketed by Tibotec, a division ofJanssen-Cilag. In Canada, PREZISTA is marketed by Tibotec, adivision of Janssen-Ortho Inc. Applica...Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
...orldwide by Janssen-Cilag (Janssen), awholly owned division of Johnson & Johnson; and VIVITROL(R)(naltrexone for extended-release injectable suspension) the firstand only once-monthly injectable medication approved for thetreatment of alcohol dependence and marketed in the U.S. primarilyby Cephalon, Inc. ......s, Inc. (NASDAQ: PGNX) and WyethPharmaceuticals, a division of Wyeth (NYSE: WYE), today announcedpositive resu...ward-looking statements. Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
...difficult-to-manufacturebiologics. Its Bioscience division helps to optimizelaboratory productivity and workflows. Its products and enablingtechnologies that are used in the laboratory are essential for theresearch and development of biologically based life sciencetherapeutics. Millipore has a deep understa...First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
...dquartered in Roanoke, Virginia. Luna nanoWorks, a division ofLuna Innovations, is located in Danville, Virginia. For more, seewww.lunainnovations.com. About VCU and the VCU Medical Center: Virginia CommonwealthUniversity is the largest university in Virginia and ranks amongthe top 100 universities in the co......mgen and Wyeth Amgen and Wyeth Pharmaceuticals, a division of Wyeth, marketENBREL in North America. Wyeth mar...nes, visitwww.amgen.com. Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin......generic products through its GlobalPharmaceuticals division and markets its branded products throughthe IMPAX Pharmaceuticals division. Additionally, wherestrategically appropriate, IMPAX has developed marketingpartnerships to fully leverage its technology platform. IMPAXLaboratories is headquartered in Haywa......veVice President, Oncology, Merck Serono – a division of MerckKGaA, Darmstadt, Germany. “We believe we have reached amilestone in oncology. Erbitux consistently adds meaningfulefficacy throughout all lines of mCRC therapy. The increasedresection rates we observed suggest a high potential to provid......rmal growth factor binds, causinguncontrolled cell division -- a predisposition for cancer. The EGFRis found at abnormally high levels on the surface of mostpancreatic cancer cells. This study examined the effectiveness ofCetuximab, an anticancer monoclonal antibody directed to block theEGFR, combined with th......ve Vice President, Oncology,Merck Serono – a division of Merck KGaA, Darmstadt,Germany. “Cilengitide is part of the Merck Serono Oncologyportfolio – led by the epidermal growth factorreceptor-targeting monoclonal antibody Erbitux® – and theclinical programs for these investigation...... the stent, is marketed byWyeth Pharmaceuticals, a division of Wyeth, under the nameRapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. SOURCE Cordis Corporation Mariela Melendez of Cordis Corporation, +1-786-313-2776, cell, +1-786-218-4084,mmelen10@crdus.jnj.com; or Todd Ringler of Edelman, +1-6...Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
...sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the Unite...... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...Antidepressant Use May Boost Fracture Risk, From Harvard Women's Health Watch
...le from Harvard HealthPublications, the publishing division of Harvard Medical School,for $24 per year. Subscribe at <a target="_blank" href="http://www.health.harvard.edu/women">http://www.health.harvard.edu/women or by calling 1-877- 649-9457 (toll free). Media: Contact Christine Junge at for a com...Mild Asthma, a Revolutionary Therapy from Italian Research
...he Italian company’sResearch and Development division – Over time this initialperception has become an increasingly evident rationale and hasgained significance in important clinical trials, such as the BESTstudy”. “On the basis of our daily experience, – explainsDr. Germano Bet......sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu......sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu......vayPharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth(NYSE:WYE), and Lundbeck A/S presented cli...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...... the stent, is marketed byWyeth Pharmaceuticals, a division of Wyeth, under the nameRapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. CONTACT: Mariela Melendez of Cordis Corporation,+1-786-218-4084,; or Todd Ringler of Edelman, +1-617-872-1235,, forCordis Corporation <a target="_blank" href=......g in San Diego,Calif., by Wyeth Pharmaceuticals, a division of Wyeth . Resultsfrom short-term studies and a si...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin......g in San Diego, Calif., by WyethPharmaceuticals, a division of Wyeth . The primary objective ofstudies include...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...Gardasil Demonstrates Up to 100% Efficacy
...a joint venture between sanofi pasteur, thevaccine division of sanofi-aventis, and Merck & Co., Inc.Combining innovation and expertise, Sanofi Pasteur MSD is the onlycompany in Europe dedicated exclusively to vaccines. Sanofi PasteurMSD is able to draw on the research expertise of sanofi pasteur andMerck ...... /PRNewswire-FirstCall/ -- WyethPharmaceuticals, a division of Wyeth , presented results from thefirst Phase 3...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin......a strategic alliance with ChrysalisTechnologies (a division of Philip Morris USA) to develop andcommercialize aerosolized SRT to address a broad range of seriousrespiratory conditions. Through this alliance, Discovery gainedexclusive rights to Chrysalis' novel aerosol generating technologyfor use with pulmona...Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
...d Matthew Weir,M.D., professor and director of the division of nephrology at theUniversity of Maryland School of Medicine. "The preliminary studyresults are very encouraging." Dr. Weir reported that first-year results in kidney transplantrecipients demonstrated that patients on CellCept and sirolimusmainte......sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the US, B......sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the US, B...Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show
... authors and associateprofessor of medicine in the division of clinical immunology andrheumatology and director of the university clinical researchcenter at the University of Texas Health Science Center, SanAntonio. "A reduction in pain is critical for people living withthis condition. With positive new data ......sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the U.S.,...Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
...le from HarvardHealth Publications, the publishing division of Harvard MedicalSchool, for $59 per year. Subscribe at <a target="_blank" href="http://www.health.harvard.edu/mental">http://www.health.harvard.edu/mental or by calling 1-877-649-9457 (toll free). Media: Contact Christine Junge at for a co...Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ......angiogenesis; and KSP, a protein required for cell division that,when inhibited, leads to cell arrest and cell death in dividingcells. ALN-VSP01 is formulated using Alnylam's novel liposomalformulation technology, which has been used to achieve delivery ofsiRNAs to cells of the liver and efficient silencing o...EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
...ive, antimitotic agent that leads toarrest of cell division and apoptosis in tumor cells. ENMD-1198also exerts antiangiogenic activity that further contributes to itsoverall antitumor effects. Results demonstrate that oral administration of ENMD-1198 waswell tolerated and produced significant dose-dependen...EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
...tural network).Microtubules are necessary for cell division (mitosis), cellstructure, transport, signaling and motility. Given their primaryrole in cell division, microtubules have been an important targetfor anticancer drugs -- often referred to as tubulin inhibitors ormicrotubule targeting agents. These com...Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 (R1645) is in Phase 1 clinical trialsin patients with solid tumors. Kosan's epothilone program ispartnered with Roche through a global deve...Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ......s being co-developed with Wyeth Pharmaceuticals, a division ofWyeth . These Phase 1b combination data demonstrate the additiveantiviral effects of HCV-796 across multiple genotypes of hepatitisC virus, in treatment-naïve adult subjects withchronic hepatitis C infection. HCV-796 dosed twice daily...Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR
...7 and CDK9, that are central to the process ofcell division and cell cycle control. Seliciclib has been evalua...le-strand DNA breaks and induces arrest ofthe cell division cycle. Both sapacitabine and its majormetabolite, CNDAC, have demonstrated in preclinical studies po...Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...... /PRNewswire-FirstCall/ --Wyeth Pharmaceuticals, a division of Wyeth , provides comment on are- analysis of po...the uterus. About Wyeth Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin......d Pharmaceuticals divisions. The USPharmaceuticals division comprises the following business units:Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics,Hematology/Cardiology, and Oncology. The company's aim is todiscover and manufacture products that will improve human healthworldwide by diagnosin...... /PRNewswire-FirstCall/ --Wyeth Pharmaceuticals, a division of Wyeth , SolvayPharmaceuticals, Inc. and Lundbec...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...... the stent, is marketed byWyeth Pharmaceuticals, a division of Wyeth, under the nameRapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. CONTACT: Mariela Melendez, Cordis Corporation, +1-786-313-2776,Cell:+1-786-218-4084, ; Todd Ringler, Edelman,+1-781-599-7542,Cell: +1-617-872-1235, <a target=......sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu......the stent, is marketed by Wyeth Pharmaceuticals, a division of Wyeth, under the name Rapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. CONTACT: Mariela Melendez of Cordis Corporation, phone,+1-786-313-2776,Cell: +1-786-218-4084, or Email: ; or Todd RinglerofEdelman for Cordis Corporation......sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu......sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu...EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
...ntenance of cell shape, cellular functions andcell division (growth). These highly dynamic filaments are composedof dimeric tubulin proteins. Microtubule targeting drugs are one ofthe most successful classes of chemotherapy agents and are used forboth solid and liquid tumors. There are three drug binding site......argeted to inhibit Aurorakinases thus halting cell division at the mitotic phase of the cellcycle and blocking the uncontrolled cellular proliferationassociated with tumor growth. Aurora kinases have been detected athigh levels in tumors from several cancer types, including colon,breast, ovarian, bladder, eso...